Skip to content

VALIDATION STUDY: NOCICEPTIVE PAIN MODEL AND PHARMACOLOGICAL INTERVENTION

VALIDATION STUDY: NOCICEPTIVE PAIN MODEL AND PHARMACOLOGICAL INTERVENTION - NOCICEPTIVE PAIN MODEL VALIDATION STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32823
Enrollment
12
Registered
2008-11-11
Start date
2008-12-08
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pijn acute pain

Interventions

Ultiva (remifentanil) and inducing light pain sensations

Sponsors

PRA International EDS
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18-40 years of age BMI 18-30

Exclusion criteria

Exclusion criteria: Evidence of clinically relevant pathology in the history

Design outcomes

Primary

MeasureTime frame
heat detection threshold (HDT), heat pain detection threshold (HPDT), heat pain, cold detection threshold (CDT), cold pain detection threshold (CPDT), cold pain, cold pressor pain, mechanical pain threshold (MPT) and pressure pain threshold (PPT) ; VAS pain intensity during heat pain, cold pain and cold pressor pain

Secondary

MeasureTime frame
AEs, oxygen saturation, heart rate and rhythm, blood pressure and respiratory rate

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)